IL13 and Alzheimer disease: reported that ILCs from AD skin frequently co-expresses type 2 (GATA3 and IL13) and type 3/17 (RORC, IL22, and IL26) molecular signatures at the single-cell level and can rapidly change their molecular, immunophenotypic, and functional characteristics upon cytokine stimulation, participating in host defense or promotion of disease onset (41).